Topics

Bristol-Myers Squibb’s Sandra Leung Pushes A Plurality of Perspectives

12:00 EDT 30 Apr 2019 | 3blmedia - Health

Sandra Leung has helped Bristol-Myers Squibb open its ears and eyes to finding the most diverse set of voices it can put on its team, but she says the work is only just beginning

SOURCE: Bristol-Myers Squibb Company

DESCRIPTION:

By Paul Snyder, Modern Counsel

“There is wide recognition that people are our most valuable resource, and to retain and attract the best people, we need to have a more diverse and inclusive environment where people feel empowered to bring their whole self to work,” says Leung, Bristol-Myers Squibb’s executive vice president and general counsel. “It’s imperative to our continued success that we embrace different voices to become a more powerful company.”

In terms of power, it’s hard to argue with the company’s current standing in the pharmaceutical world. With more than twenty thousand employees around the globe and $20.8 billion in revenue in 2017, Bristol-Myers Squibb is one of the largest players in its industry.

That’s in no small part thanks to the diverse workforce that the company has cultivated, Leung says, and maintaining it is an ongoing effort that takes place at the company’s locations around the world.

Continue reading on Modern Counsel

Tweet me: #Diversity and #inclusion key to Bristol-Myers Squibb's success - supports business operations, #careeradvancement and #employeeengagement https://bit.ly/2V7JeEq @BMSnews @ModernCounsel

KEYWORDS: Bristol-Myers Squibb, Sandra Leung, Modern Counsel, Paul Snyder

Original Article: Bristol-Myers Squibb’s Sandra Leung Pushes A Plurality of Perspectives

NEXT ARTICLE

More From BioPortfolio on "Bristol-Myers Squibb’s Sandra Leung Pushes A Plurality of Perspectives"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...